LncRNA ASMTL-AS1/microRNA-1270 Differentiate Prognostic Groups in Gastric Cancer and Influence Cell Proliferation, Migration and Invasion

Overview

Journal Bioengineered

Date 2022 Jan 6

PMID 34986743

Citations 6

Authors

Zhenhe Song

Jian Wang

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to determine the expression levels of ASMTL-AS1 and miR-1270 in gastric cancer, and to explore whether ASMTL-AS1 and miR-1270 is associated with cancer prognosis and progression or not. ASMTL-AS1 and miR-1270 expression were quantified in gastric cancer tissues and adjacent normal tissues (n = 167) and cell lines. The potential of ASMTL-AS1 and miR-1270 as prognostic biomarkers was evaluated by the receiver operating characteristic (ROC) curve, Kaplan-Meier, and multivariate Cox regression analyses. The binding between ASMTL-AS1 and miR-1270 was verified by the Luciferase reporter assay and RNA pull-down assay. Functional roles of ASMTL-AS1/miR-1270 on cells were investigated in HGC-27 and NCI-N87 cells by MTS viability, Transwell migration, and Matrigel invasion assay. ASMTL-AS1 was significantly downregulated while miR-1270 was upregulated in gastric cancer tissues as compared with normal tissue and cell lines. According to the studies, ASMTL-AS1 and miR-1270 were related to unfavorable clinical parameters, such as the advanced TNM stage. Downregulated ASMTL-AS1 and upregulated miR-1270 were associated with reduced 5-year overall survival. Functional studies suggested that ASMTL-AS1 inhibits proliferation, migration, and invasion of HGC-27 and NCI-N87 cells by regulation of miR-1270. In summary, ASMTL-AS1 and miR-1270 are associated with poor prognosis of patients with gastric cancer. ASMTL-AS1 inhibited gastric cancer progression by regulating miR-1270. Therefore, ASMTL-AS1/miR-1270 may be a potential prognostic biomarker and novel strategy for gastric cancer targeted therapy.

Citing Articles

Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis.

Tsai K, Liao J, Tseng H Cancer Cell Int. 2024; 24(1):384.

PMID: 39563323 PMC: 11575040. DOI: 10.1186/s12935-024-03545-5.

The homologous tumor-derived-exosomes loaded with miR-1270 selectively enhanced the suppression effect for colorectal cancer cells.

Jin Y, Sun L, Chen Y, Lu Y Cancer Med. 2024; 13(1):e6936.

PMID: 38197582 PMC: 10807586. DOI: 10.1002/cam4.6936.

Licochalcone A Inhibits Proliferation and Metastasis of Colon Cancer by Regulating miR-1270/ADAM9/Akt/NF-κB axis.

Pan C, Chen H, Yang B Iran J Public Health. 2023; 52(9):1962-1972.

PMID: 38033851 PMC: 10682590. DOI: 10.18502/ijph.v52i9.13578.

Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer.

Wang Z, Liang X, Zhang H, Wang Z, Zhang X, Dai Z J Immunol Res. 2022; 2022:5209607.

PMID: 36052279 PMC: 9427269. DOI: 10.1155/2022/5209607.

CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis.

Gu Q, Hou W, Shi L, Zhu Z, Liu H, He X Bioengineered. 2022; 13(4):10734-10748.

PMID: 35475453 PMC: 9208511. DOI: 10.1080/21655979.2022.2054161.

References

Mazza T, Copetti M, Capocefalo D, Fusilli C, Biagini T, Carella M . MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma. Oncotarget. 2017; 8(62):105320-105339. PMC: 5739641. DOI: 10.18632/oncotarget.22184. View

Shi J, Yao D, Liu W, Wang N, Lv H, He N . Frequent gene amplification predicts poor prognosis in gastric cancer. Int J Mol Sci. 2012; 13(4):4714-4726. PMC: 3344242. DOI: 10.3390/ijms13044714. View

Eloranta S, Smedby K, Dickman P, Andersson T . Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis. J Intern Med. 2020; 289(1):12-28. DOI: 10.1111/joim.13139. View

Goodall G, Wickramasinghe V . RNA in cancer. Nat Rev Cancer. 2020; 21(1):22-36. DOI: 10.1038/s41568-020-00306-0. View

Sexton R, Al Hallak M, Diab M, Azmi A . Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020; 39(4):1179-1203. PMC: 7680370. DOI: 10.1007/s10555-020-09925-3. View

Grady W, Yu M, Markowitz S . Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology. 2020; 160(3):690-709. PMC: 7878343. DOI: 10.1053/j.gastro.2020.09.058. View

Anastasiadou E, Jacob L, Slack F . Non-coding RNA networks in cancer. Nat Rev Cancer. 2017; 18(1):5-18. PMC: 6337726. DOI: 10.1038/nrc.2017.99. View

Luo Z, Xiao L, Li J, Dong B, Wang C . Integrative analysis reveals driver long non-coding RNAs in osteosarcoma. Medicine (Baltimore). 2019; 98(6):e14302. PMC: 6380806. DOI: 10.1097/MD.0000000000014302. View

Zhong L, Zheng C, Fang H, Xu M, Chen B, Li C . MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma. IUBMB Life. 2018; 70(7):625-632. DOI: 10.1002/iub.1753. View

10.

Ma D, Gao X, Liu Z, Lu X, Ju H, Zhang N . Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation. Cell Prolif. 2020; 53(9):e12795. PMC: 7507479. DOI: 10.1111/cpr.12795. View

11.

Feng Z, Chen R, Huang N, Luo C . Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Life Sci. 2020; 244:117298. DOI: 10.1016/j.lfs.2020.117298. View

12.

Yin D, Lu X . Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Bioengineered. 2020; 12(1):225-239. PMC: 8806318. DOI: 10.1080/21655979.2020.1863619. View

13.

Weng L, Wu X, Gao H, Mu B, Li X, Wang J . MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol. 2010; 222(1):41-51. DOI: 10.1002/path.2736. View

14.

Yuan W, Zhou R, Wang J, Han J, Yang X, Yu H . Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition. Mol Oncol. 2019; 13(7):1559-1576. PMC: 6599840. DOI: 10.1002/1878-0261.12523. View

15.

Kang J, Yoon S, Kim N, Heo D . The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines. Int J Oncol. 2000; 16(6):1159-63. DOI: 10.3892/ijo.16.6.1159. View

16.

Wei J, Huang K, Yang C, Kang C . Non-coding RNAs as regulators in epigenetics (Review). Oncol Rep. 2016; 37(1):3-9. DOI: 10.3892/or.2016.5236. View

17.

Weidle U, Birzele F, Nopora A . microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis. Cancer Genomics Proteomics. 2021; 18(1):1-15. PMC: 7796821. DOI: 10.21873/cgp.20237. View

18.

Sui X, Hu N, Zhang Z, Wang Y, Wang P, Xiu G . ASMTL-AS1 impedes the malignant progression of lung adenocarcinoma by regulating SAT1 to promote ferroptosis. Pathol Int. 2021; 71(11):741-751. DOI: 10.1111/pin.13158. View

19.

Mou Y, Sun Q . The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1). Bioengineered. 2021; 13(1):746-758. PMC: 8805813. DOI: 10.1080/21655979.2021.2012628. View

20.

Chan J, Tay Y . Noncoding RNA:RNA Regulatory Networks in Cancer. Int J Mol Sci. 2018; 19(5). PMC: 5983611. DOI: 10.3390/ijms19051310. View